WHO Approves Two New Covid 19 Treatments

covid treatment
Credit: Pixabay/CC0 Public Domain
The World Health Organization approved two new Covid-19 treatments on Friday, growing the arsenal of tools along with vaccines to stave off severe illness and death from the virus.

The news comes as Omicron cases fill hospitals around the world with the WHO predicting half of Europe will be infected by March.

In their recommendation in British medical Journal the BMJ, WHO experts said arthritis drug baricitinib used with corticosteroids to treat severe or critical Covid patients led to better survival rates and reduced need for ventilators.

Experts also recommended synthetic antibody treatment Sotrovimab for people with non-serious Covid at highest risk of hospitalisation, such as the elderly, people with immunodeficiencies or chronic diseases such as diabetes.

Sotrovimab's benefits for people not at risk of hospitalisation were deemed insignificant and the WHO said its effectiveness against new variants like Omicron was "still uncertain".

Only three other treatments for Covid-19 have received WHO approval, starting with corticosteroids for severely ill patients in September 2020.

Corticosteroids are inexpensive and widely available and fight inflammation that commonly accompanies severe cases.

Arthritis drugs tocilizumab and sarilumab, which the WHO endorsed in July, are IL-6 inhibitors that suppress a dangerous overreaction of the immune system to the SARS-CoV-2 virus.

Baricitinib is in a different class of drugs known as Janus kinase inhibitors, but it falls under the same guidelines as the IL-6 inhibitors.

"When both are available, choose one based on issues including cost and clinician experience," the guidelines say.

Synthetic antibody treatment Regeneron was approved by the WHO in September and the guidelines say Sotrovimab can be used for the same type of patients.

The WHO's Covid treatment recommendations are updated regularly based on new data from clinical trials.


Explore further

WHO recommends two new drugs to treat patients with COVID-19

Journal information: cite">>British Medical Journal (BMJ) >

© 2022 AFP

Citation: WHO approves two new Covid-19 treatments (2022, January 14) retrieved 24 January 2022 from https://medicalxpress.com/news/2022-01-covid-treatments.html

Source : https://medicalxpress.com/news/2022-01-covid-treatments.html

492
WHO approves two new treatments for COVID-19: All you need to know about Baricitinib and Sotrovimab

Source:Firstpost

WHO approves two new treatments for COVID-19: All you need to know about Baricitinib and Sotrovimab

WHO Approves Two New Covid-19 Treatments, One Is Arthritis Drug Baricitinib

Source:TheHealthSite

WHO Approves Two New Covid-19 Treatments, One Is Arthritis Drug Baricitinib

WHO Approves Two New Treatments For Coronavirus, Including Arthritis Drug

Source:NDTV

WHO Approves Two New Treatments For Coronavirus, Including Arthritis Drug

Two new Covid-19 treatments have been approved by WHO. See details

Source:Mint

Two new Covid-19 treatments have been approved by WHO. See details

Australia approves two new medicines in the fight against COVID-19. How can you get them and are they effective against Omicron?

Source:moneycontrol.com

Australia approves two new medicines in the fight against COVID-19. How can you get them and are they effective against Omicron?

WHO Approves Two New Treatments For Covid-19, Baricitinib And Sotrovimab

Source:Onlymyhealth

WHO Approves Two New Treatments For Covid-19, Baricitinib And Sotrovimab